CS
FOMX

Credit Suisse’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History

Credit Suisse’s Portfolio FOMX Stock Details FOMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-33,952
Closed -$194K – 4073
2018
Q3 		$194K Buy
+33,952
New +$194K ﹤0.01% 3661
2017
Q1 		– Sell
-15,602
Closed -$173K – 4192
2016
Q4 		$173K Sell
15,602
-4,685
-23% -$44.1K ﹤0.01% 3851
2016
Q3 		$188K Sell
20,287
-70,435
-78% -$589K ﹤0.01% 3830
2016
Q2 		$576K Buy
+90,722
New +$602K ﹤0.01% 3328
2016
Q1 		– Sell
-20,224
Closed -$165K – 4407
2015
Q4 		$165K Buy
20,224
+9,092
+82% +$68K ﹤0.01% 3966
2015
Q3 		$81K Buy
+11,132
New +$113K ﹤0.01% 4129

Other funds holding FOMX

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

Credit Suisse's FOMX Position: Q4 2018 in Review

Credit Suisse sold out of Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) in Q4 2018, closing a stake of 33,952 shares — an estimated $194K sold.

Credit Suisse first reported a position in FOMX in Q3 2015 and held it in 6 quarters. The position peaked at $576K in Q2 2016. 66 funds tracked by Wall St. Rank hold FOMX as of Q4 2018.

  • Credit Suisse reported no remaining Foamix Pharmaceuticals Ltd. Ordinary Shares position as of Q4 2018 after selling out during the quarter.
  • Credit Suisse sold 33,952 Foamix Pharmaceuticals Ltd. Ordinary Shares shares in Q4 2018, an estimated $194K.
  • Credit Suisse first reported a position in Foamix Pharmaceuticals Ltd. Ordinary Shares in Q3 2015 and held it in 6 quarters.
  • Credit Suisse's Foamix Pharmaceuticals Ltd. Ordinary Shares position peaked at $576K in Q2 2016.
  • 66 funds tracked by Wall St. Rank held Foamix Pharmaceuticals Ltd. Ordinary Shares as of Q4 2018.

Based on Credit Suisse's 13F filing for Q4 2018, filed 13 Feb 2019.